Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (26)

2024

  1. Effects of COVID-19 lockdown on children´s sleep quality, physical activity, screen time, and diet

    Nutricion Hospitalaria, Vol. 41, Núm. 4, pp. 781-787

  2. Higher adherence to the Mediterranean Diet is associated with lower micronutrient inadequacy in children: the SENDO project

    Public Health Nutrition, Vol. 27, Núm. 1

  3. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials

    BJS open, Vol. 8, Núm. 5

2023

  1. A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 44, pp. 50638-50651

  2. Breastfeeding Is Associated with Higher Adherence to the Mediterranean Diet in a Spanish Population of Preschoolers: The SENDO Project

    Nutrients, Vol. 15, Núm. 5

  3. Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene

    Stem Cell Research, Vol. 71

  4. Higher adherence to the Mediterranean Diet is associated with lower micronutrient inadequacy in children: the SENDO project

    Public health nutrition, Vol. 27, Núm. 1, pp. e8

  5. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

    Journal of Translational Medicine, Vol. 21, Núm. 1

  6. Longer Breastfeeding Duration is Associated With Lower Consumption of Ultraprocessed Foods in a Sample of Spanish Preschoolers: The SENDO Project

    Journal of the Academy of Nutrition and Dietetics, Vol. 123, Núm. 11, pp. 1555-1567

  7. PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

    Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526

2022

  1. Novel strategies exploiting interleukin-12 in cancer immunotherapy

    Pharmacology and Therapeutics, Vol. 239

2021

  1. Endolymphatic Hydrops in Fluctuating Hearing Loss and Recurrent Vertigo

    Frontiers in Surgery, Vol. 8

  2. Intratumoural administration and tumour tissue targeting of cancer immunotherapies

    Nature Reviews Clinical Oncology, Vol. 18, Núm. 9, pp. 558-576

  3. Paradigms on immunotherapy combinations with chemotherapy

    Cancer Discovery, Vol. 11, Núm. 6, pp. 1353-1367

2020

  1. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

    EJNMMI Physics, Vol. 7, Núm. 1

2019

  1. Cytokines in clinical cancer immunotherapy

    British Journal of Cancer, Vol. 120, Núm. 1, pp. 6-15

  2. Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

    Drug Safety, Vol. 42, Núm. 2, pp. 281-294

2018

  1. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  2. International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain

    Cancer Immunology, Immunotherapy

  3. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139